# OnCo record tinzaparin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tinzaparin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tinzaparin" ;
  schema:name "Tinzaparin"@en ;
  schema:alternateName "tinzaparin sodium"@en, "Innohep" ;
  schema:description "Tinzaparin is a once-daily blood-thinning injection used in the UK and Europe to treat and prevent clots, including long-term treatment of a clot in people with active cancer."@en ;
  schema:url <https://onco.cc/drugs/tinzaparin/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Tinzaparin_sodium> ;
  schema:citation <https://www.medicines.org.uk/emc/product/13848/smpc>, <https://www.medicines.org.uk/emc/product/13847/smpc>, <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1513b960-d9d1-11de-8a1e-0002a5d5c51b>, <https://doi.org/10.1016/S1470-2045(22)00160-7> ;
  onco:status "approved" ;
  onco:tag "supportive", "generic", "supportive-care-gaps-2026-11" ;
  onco:modality "Low-molecular-weight heparin (injection)" ;
  onco:approval "UK 1994: Treatment of DVT and PE; extended treatment of venous thromboembolism and prevention of recurrences in adults with active cancer" ;
  onco:related <https://onco.cc/drugs/enoxaparin/>, <https://onco.cc/drugs/dalteparin/>, <https://onco.cc/drugs/warfarin/> ;
  onco:technologies <https://onco.cc/technologies/cancer-associated-thrombosis/> ;
  onco:terms <https://onco.cc/terms/vte/> .